Mortality, Stroke, and Hospitalization Associated With Deferred vs Expedited Aortic Valve Replacement in Patients Referred for Symptomatic Severe Aortic Stenosis During the COVID-19 Pandemic

Samankaltaisia teoksia

• Deferred versus Expedited Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis During the SARS-CoV-2 Pandemic (AS DEFER): A Research Letter
  Tekijä: Lanz, Jonas, et al.
  Julkaistu: (2021)
• Staging cardiac damage associated with aortic stenosis in patients undergoing transcatheter aortic valve implantation
  Tekijä: Okuno, Taishi, et al.
  Julkaistu: (2021)
• Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trial
  Tekijä: Christoph Ryffel, et al.
  Julkaistu: (2025-07-01)
• Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era
  Tekijä: Matthew Brennan, J., et al.
  Julkaistu: (2020)
• Transcatheter versus surgical aortic valve replacement in severe, symptomatic aortic stenosis
  Tekijä: Tsigkas, Grigorios, et al.
  Julkaistu: (2018)